Overall, the data shows that the expression of immune checkpoints was significantly higher in both OL and OM tumors compared to normal tissues, with the OM type demonstrating even higher expression levels of specific immune checkpoints (PD1, IDO2), and lower expression of PDL2 (Table 3). The gene discussed is IDO2; the disease is ocular melanoma.